Sirnaomics Ltd 2257.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 4:09 PM CTT
6.06quote price arrow up+0.19 (+3.24%)
Volume
4,938,950
52 week range
5.64 - 59.00
Loading...
  • Open5.97
  • Day High6.32
  • Day Low5.86
  • Prev Close5.87
  • 52 Week High59.00
  • 52 Week High Date07/25/23
  • 52 Week Low5.64
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap64.88M
  • Shares Out87.64M
  • 10 Day Average Volume5.49M
  • Dividend-
  • Dividend Yield-
  • Beta-0.14
  • YTD % Change-83.07

KEY STATS

  • Open5.97
  • Day High6.32
  • Day Low5.86
  • Prev Close5.87
  • 52 Week High59.00
  • 52 Week High Date07/25/23
  • 52 Week Low5.64
  • 52 Week Low Date04/22/24
  • Market Cap64.88M
  • Shares Out87.64M
  • 10 Day Average Volume5.49M
  • Dividend-
  • Dividend Yield-
  • Beta-0.14
  • YTD % Change-83.07

RATIOS/PROFITABILITY

  • EPS (TTM)-8.08
  • P/E (TTM)-0.75
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sirnaomics Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a sterile drug product for the treatment of...
Yang Lu Ph.D.
Executive Chairman of the Board, President, Chief Executive Officer, Founder
Wing Kei Yip
Group Chief Financial Officer, Vice President - Corporate Finance
Address
401 Professional Drive, Suite 280
Gaithersburg, MD
20879
United States